Completion of share buyback programme

ANNOUNCEMENT NO. 316
2 October 2026

ChemoMetec A/S has completed the share buyback programme announced in company announcement no. 309 dated 15 May 2026. The programme provided for the repurchase of up to 500,000 shares for a total consideration of up to DKK 100 million.

Under the programme, ChemoMetec A/S repurchased a total of 239,950 shares for a total consideration of DKK 99,998,735.

Following completion of the programme, ChemoMetec A/S holds a total of 239,950 treasury shares, corresponding to 1.38% of the company’s share capital.

Additional Information

Martin Helbo Behrens, CEO
Tel.: (+45) 81 10 06 80 

Phillip Massie Price, CFO
Tel.: (+45) 81 10 06 80 

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com.

You May Also Be Interested In

• DP World Wins LatinFinance Port Financing of the Year Award in Brazil
• Major shareholder announcement
• NACON ANNOUNCES THE REVOLUTION 5 UNLIMITED, THE NEW HIGH-END CONTROLLER FOR PLAYSTATION®5 CONSOLES AND PC*